» Articles » PMID: 35487970

Proteomics of Lung Tissue Reveals Differences in Inflammation and Alveolar-capillary Barrier Response Between Atelectasis and Aerated Regions

Overview
Journal Sci Rep
Specialty Science
Date 2022 Apr 29
PMID 35487970
Authors
Affiliations
Soon will be listed here.
Abstract

Atelectasis is a frequent clinical condition, yet knowledge is limited and controversial on its biological contribution towards lung injury. We assessed the regional proteomics of atelectatic versus normally-aerated lung tissue to test the hypothesis that immune and alveolar-capillary barrier functions are compromised by purely atelectasis and dysregulated by additional systemic inflammation (lipopolysaccharide, LPS). Without LPS, 130 proteins were differentially abundant in atelectasis versus aerated lung, mostly (n = 126) with less abundance together with negatively enriched processes in immune, endothelial and epithelial function, and Hippo signaling pathway. Instead, LPS-exposed atelectasis produced 174 differentially abundant proteins, mostly (n = 108) increased including acute lung injury marker RAGE and chemokine CCL5. Functional analysis indicated enhanced leukocyte processes and negatively enriched cell-matrix adhesion and cell junction assembly with LPS. Additionally, extracellular matrix organization and TGF-β signaling were negatively enriched in atelectasis with decreased adhesive glycoprotein THBS1 regardless of LPS. Concordance of a subset of transcriptomics and proteomics revealed overlap of leukocyte-related gene-protein pairs and processes. Together, proteomics of exclusively atelectasis indicates decreased immune response, which converts into an increased response with LPS. Alveolar-capillary barrier function-related proteomics response is down-regulated in atelectasis irrespective of LPS. Specific proteomics signatures suggest biological mechanistic and therapeutic targets for atelectasis-associated lung injury.

Citing Articles

Clinical significance of postoperative thrombocytosis after vats lobectomy for NSCLC.

Leonardi B, Natale G, Ferraioli S, Leone F, Grande M, Puca M J Cardiothorac Surg. 2024; 19(1):529.

PMID: 39272103 PMC: 11401256. DOI: 10.1186/s13019-024-03032-y.


Prone Positioning and Molecular Biomarkers in COVID and Non-COVID ARDS: A Narrative Review.

Spadaro S, Jimenez-Santana J, La Rosa R, Spinazzola G, Navarro P, Volta C J Clin Med. 2024; 13(2).

PMID: 38256451 PMC: 10816213. DOI: 10.3390/jcm13020317.


Programmed cell death 4 governs NLRP3-mediated pyroptosis in septic lung disorders.

Du W, Ren N, Xu Y, Chen X Mol Biol Rep. 2024; 51(1):77.

PMID: 38183433 DOI: 10.1007/s11033-023-08948-7.


Personalized medicine using omics approaches in acute respiratory distress syndrome to identify biological phenotypes.

Battaglini D, Al-Husinat L, Normando A, Leme A, Franchini K, Morales M Respir Res. 2022; 23(1):318.

PMID: 36403043 PMC: 9675217. DOI: 10.1186/s12931-022-02233-0.

References
1.
Retamal J, Bergamini B, Carvalho A, Bozza F, Borzone G, Borges J . Non-lobar atelectasis generates inflammation and structural alveolar injury in the surrounding healthy tissue during mechanical ventilation. Crit Care. 2014; 18(5):505. PMC: 4172813. DOI: 10.1186/s13054-014-0505-1. View

2.
Jabaudon M, Blondonnet R, Ware L . Biomarkers in acute respiratory distress syndrome. Curr Opin Crit Care. 2020; 27(1):46-54. PMC: 7774234. DOI: 10.1097/MCC.0000000000000786. View

3.
Rancan L, Paredes S, Huerta L, Casanova J, Guzman J, Garutti I . Chemokine Involvement in Lung Injury Secondary to Ischaemia/Reperfusion. Lung. 2017; 195(3):333-340. DOI: 10.1007/s00408-017-0001-x. View

4.
Krupa A, Fol M, Rahman M, Stokes K, Florence J, Leskov I . Silencing Bruton's tyrosine kinase in alveolar neutrophils protects mice from LPS/immune complex-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2014; 307(6):L435-48. PMC: 4166786. DOI: 10.1152/ajplung.00234.2013. View

5.
de Prost N, Feng Y, Wellman T, Tucci M, Costa E, Musch G . 18F-FDG kinetics parameters depend on the mechanism of injury in early experimental acute respiratory distress syndrome. J Nucl Med. 2014; 55(11):1871-7. PMC: 4258066. DOI: 10.2967/jnumed.114.140962. View